BlackRock Fund Advisors’s Microbot Medical MBOT Stock Holding History

BlackRock Fund Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2K	Sell	18 -223	-93%	-$28.2K	﹤0.01%	4150
2016 Q3	$44K	Buy	241 +227	+1,621%	+$29.6K	﹤0.01%	3809
2016 Q2	$1K	Buy	14 +1	+8%	+$288	﹤0.01%	4272
2016 Q1	$5K	Buy	13 +3	+30%	+$1.58K	﹤0.01%	4088
2015 Q4	$7K	Buy	+10	New	+$7.34K	﹤0.01%	4074
2015 Q2	–	Sell	-106	Closed	-$176K	–	3887
2015 Q1	$176K	Sell	106 -8	-7%	-$14.3K	﹤0.01%	3513
2014 Q4	$173K	Buy	114 +9	+9%	+$16.3K	﹤0.01%	3521
2014 Q3	$215K	Buy	105 +4	+4%	+$10.6K	﹤0.01%	3442
2014 Q2	$333K	Buy	101 +3	+3%	+$6.92K	﹤0.01%	3307
2014 Q1	$213K	Buy	98 +12	+14%	+$28.7K	﹤0.01%	3450
2013 Q4	$172K	Buy	86 +3	+4%	+$6.35K	﹤0.01%	3477
2013 Q3	$225K	Buy	83 +7	+9%	+$19K	﹤0.01%	3351
2013 Q2	$203K	Buy	+76	New	+$214K	﹤0.01%	3310

Other funds holding MBOT

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

DSC

Duncker Streett & Co St. Louis, Missouri $526M AUM 22.2% 1-Year Est. Return

BlackRock Fund Advisors's MBOT Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Microbot Medical (MBOT) stake by 93% in Q4 2016, selling an estimated $28.2K and leaving 18 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #4150.

BlackRock Fund Advisors first reported a position in MBOT in Q2 2013 and has held it in 13 quarters since. The position peaked at $333K in Q2 2014. 18 funds tracked by Wall St. Rank hold MBOT as of Q4 2016.

BlackRock Fund Advisors held 18 shares of Microbot Medical worth $2K as of Q4 2016.
BlackRock Fund Advisors sold 223 Microbot Medical shares in Q4 2016, an estimated $28.2K.
Microbot Medical made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4150 holding.
BlackRock Fund Advisors first reported a position in Microbot Medical in Q2 2013 and has held it in 13 quarters since.
BlackRock Fund Advisors's Microbot Medical position peaked at $333K in Q2 2014.
18 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.